BDBM504310 3α,7α,11β-trihydroxy-6α-ethyl-22-(1,2,4-oxadiazol-5-oxo-3-yl)-23,24-bisnor-5β-cholane ::US11034717, Compound 6

SMILES CC[C@H]1[C@@H](O)C2C3CC[C@H]([C@H](C)Cc4nc(=O)o[nH]4)[C@@]3(C)C[C@H](O)C2[C@@]2(C)CC[C@@H](O)C[C@@H]12

InChI Key

Data  5 EC50

Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 5 hits for monomerid = 504310   

TargetRNA-binding protein FXR1(Human)
Intercept Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM504310(3α,7α,11β-trihydroxy-6α-ethyl-...)
Show SMILES CC[C@H]1[C@@H](O)C2C3CC[C@H]([C@H](C)Cc4nc(=O)o[nH]4)[C@@]3(C)C[C@H](O)C2[C@@]2(C)CC[C@@H](O)C[C@@H]12
Affinity DataEC50:  42nMAssay Description:AlphaScreen was used with the aim of identifying novel modulators by taking advantage of the bimolecular interaction prevailing between FXR and the L...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetRNA-binding protein FXR1(Human)
Intercept Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM504310(3α,7α,11β-trihydroxy-6α-ethyl-...)
Show SMILES CC[C@H]1[C@@H](O)C2C3CC[C@H]([C@H](C)Cc4nc(=O)o[nH]4)[C@@]3(C)C[C@H](O)C2[C@@]2(C)CC[C@@H](O)C[C@@H]12
Affinity DataEC50:  42nMAssay Description:AlphaScreen was used with the aim of identifying novel modulators by taking advantage of the bimolecular interaction prevailing between FXR and the L...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetFMR1 autosomal homolog 1(Dog)
Intercept Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM504310(3α,7α,11β-trihydroxy-6α-ethyl-...)
Show SMILES CC[C@H]1[C@@H](O)C2C3CC[C@H]([C@H](C)Cc4nc(=O)o[nH]4)[C@@]3(C)C[C@H](O)C2[C@@]2(C)CC[C@@H](O)C[C@@H]12
Affinity DataEC50:  800nMAssay Description:AlphaScreen was used with the aim of identifying novel modulators by taking advantage of the bimolecular interaction prevailing between FXR and the L...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetRNA-binding protein FXR1(Rat)
Intercept Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM504310(3α,7α,11β-trihydroxy-6α-ethyl-...)
Show SMILES CC[C@H]1[C@@H](O)C2C3CC[C@H]([C@H](C)Cc4nc(=O)o[nH]4)[C@@]3(C)C[C@H](O)C2[C@@]2(C)CC[C@@H](O)C[C@@H]12
Affinity DataEC50:  240nMAssay Description:AlphaScreen was used with the aim of identifying novel modulators by taking advantage of the bimolecular interaction prevailing between FXR and the L...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
TargetRNA-binding protein FXR1(Mouse)
Intercept Pharmaceuticals, Inc.

US Patent
LigandPNGBDBM504310(3α,7α,11β-trihydroxy-6α-ethyl-...)
Show SMILES CC[C@H]1[C@@H](O)C2C3CC[C@H]([C@H](C)Cc4nc(=O)o[nH]4)[C@@]3(C)C[C@H](O)C2[C@@]2(C)CC[C@@H](O)C[C@@H]12
Affinity DataEC50:  270nMAssay Description:AlphaScreen was used with the aim of identifying novel modulators by taking advantage of the bimolecular interaction prevailing between FXR and the L...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid